Hypoxia may be a determinative factor in COVID-19 progression

• Asıl Yazarlar: Pawel Grieb (Yazar), Maciej Swiatkiewicz (Yazar), Katarzyna Prus (Yazar), Konrad Rejdak (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract:: The disease which develops following SARS-CoV-2 virus infection, known as COVID-19, in most affected countries displays mortality from 1.5% to 9.8%. When leukocytosis due to granulocytosis, thrombocytopenia, and increased level of D-dimers are detected early during the disease course, the...